Prostate Cancer and Prostatic Diseases

Welcome to Prostate Cancer and Prostatic Diseases

Featured

ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer – an interim analysis

Ronald Tutrone
Ben Lowentritt
Johan Skog
ArticleOpen Access16 May 2023
Artificial intelligence applications in prostate cancer

Atallah Baydoun
Angela Y. Jia
Daniel E. Spratt
Review Article09 Jun 2023
Characterisation of cell lines derived from prostate cancer patients with localised disease

Leire Moya
Carina Walpole
Jyotsna Batra
ArticleOpen Access01 Jun 2023
Quality of information and appropriateness of ChatGPT outputs for urology patients

Andrea Cocci
Marta Pezzoli
Emil Durukan
Article29 Jul 2023

Current issue

“Targeted microwave ablation: another way to kick the can(cer) down the road?”

Ting Martin Ma
Amar U. Kishan
Editorial11 Oct 2022
Understanding biochemical recurrence after radical prostatectomy: trust biology, not a number

Simone Albisinni
Romain Diamand
Editorial02 Feb 2023
Working hard or hardly working? A brief commentary of latest research on exercise and prostate cancer

Gloria Cecilia Galván
Sanjay Das
Stephen J. Freedland
Editorial02 Feb 2023
Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis

Giorgio Ivan Russo
Timo Soeterik
Giorgio Gandaglia
Review Article10 Oct 2022
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine

Filippo Marino
Angelo Totaro
Emilio Sacco
Review Article24 Nov 2022
Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients—a systematic review and meta-analysis

Tamás Fazekas
Ádám D. Széles
Tibor Szarvas
Review ArticleOpen Access12 Dec 2022

Contents

View all issues

Announcements

NEW COLLECTION: Working hard or hardly working?

Featuring the latest research published in Prostate Cancer and Prostatic Diseases (PCAN) in recent years relating to the link between physical activity and prostate cancer.
NEW COLLECTION: A healthy diet, a healthy prostate?

Featuring the latest research published in Prostate Cancer and Prostatic Diseases (PCAN) in recent years relating to the link between obesity and dietary factors with prostate cancer.
NEW COLLECTION: Disparities in diagnosis and management

In this collection we present papers from recent years by some of the top investigators within the field, highlighting recognized disparities in prostate cancer care, from screening to risk stratification and treatments employed in patient care pathways.
Get your manuscript ready for journal editors

Follow our checklist to avoid common mistakes to help get your manuscript to journal editors faster. We also offer a FREE language check from our partner AJE.

Prostate Cancer and Prostatic Diseases is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.

Browse articles

High-risk biochemical recurrence of locally treated prostate cancer after EMBARK. An end to decades of conventional wisdom?

Vérane Achard
Bertrand Tombal
PerspectiveOpen Access08 Dec 2023
Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases

Irene M. Shui
Mehmet Burcu
Ravi B. Parikh
ArticleOpen Access06 Dec 2023
Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer

Zhenchao Zhang
Rui Luo
Hushan Yang
Article06 Dec 2023
Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study

Yan Hiu Athena Lee
Jeremy Man Ho Hui
Chi Fai Ng
ArticleOpen Access05 Dec 2023
Reevaluating ‘Top-Down’ HoLEP: the case for anterior fibromuscular stroma as a surgical landmark

Yu-Hsiang Lin
Horng-Heng Juang
Correspondence02 Dec 2023
Impact of medical treatment on storage and voiding LUTS, nocturia, and quality of life in men at risk for progression

Mauro Gacci
Pantelis Makrides
Pietro Spatafora
Editorial01 Dec 2023
The relative impact of lymph-node metastasis and seminal vesical invasion on oncologic outcomes following radical prostatectomy

Claudia Kesch
Giorgio Calleris
Guillaume Ploussard
Editorial29 Nov 2023
Comparison of ¹⁸F-based PSMA radiotracers with [⁶⁸Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer—a systematic review and meta-analysis

Siyu Huang
Sean Ong
Marlon Perera
Review ArticleOpen Access28 Nov 2023
Comparison of procedural anxiety and pain associated with conventional transrectal ultrasound prostate biopsy to magnetic resonance imaging-ultrasound fusion-guided biopsy: a prospective cohort trial

Sriram Deivasigamani
Eric S. Adams
Thomas J. Polascik
Article25 Nov 2023

The Emerging Leaders collection welcomes and recognizes new talent in the oncology field. This collection acknowledges groundbreaking researchers, clinicians, and educators who are still in the early stages of their scientific careers. It serves as a platform to showcase Emerging Leaders and their exciting work in the prostate cancer and prostatic diseases field.

Collection 01 Jul 2023

Trending - Altmetric

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

Welcome to Prostate Cancer and Prostatic Diseases

Featured

ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer – an interim analysis

Artificial intelligence applications in prostate cancer

Characterisation of cell lines derived from prostate cancer patients with localised disease

Quality of information and appropriateness of ChatGPT outputs for urology patients

Current issue

“Targeted microwave ablation: another way to kick the can(cer) down the road?”

Understanding biochemical recurrence after radical prostatectomy: trust biology, not a number

Working hard or hardly working? A brief commentary of latest research on exercise and prostate cancer

Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis

Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine

Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients—a systematic review and meta-analysis

Announcements

NEW COLLECTION: Working hard or hardly working?

NEW COLLECTION: A healthy diet, a healthy prostate?

NEW COLLECTION: Disparities in diagnosis and management

Get your manuscript ready for journal editors

Browse articles

High-risk biochemical recurrence of locally treated prostate cancer after EMBARK. An end to decades of conventional wisdom?

Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases

Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer

Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study

Reevaluating ‘Top-Down’ HoLEP: the case for anterior fibromuscular stroma as a surgical landmark

Impact of medical treatment on storage and voiding LUTS, nocturia, and quality of life in men at risk for progression

The relative impact of lymph-node metastasis and seminal vesical invasion on oncologic outcomes following radical prostatectomy

Comparison of ¹⁸F-based PSMA radiotracers with [⁶⁸Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer—a systematic review and meta-analysis

Comparison of procedural anxiety and pain associated with conventional transrectal ultrasound prostate biopsy to magnetic resonance imaging-ultrasound fusion-guided biopsy: a prospective cohort trial

Collections

Emerging Leaders in Prostate Cancer and Prostatic Diseases

Trending - Altmetric

Search

Quick links

Featured

Announcements

Advertisement

Trending - Altmetric

Processed and raw tomato consumption and risk of prostate cancer: a systematic review and dose–response meta-analysis

A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer—the UK NCRN Pomi-T study

Association between vasectomy and risk of prostate cancer: a meta-analysis

Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases

Search

Quick links